phenylalanine and sorafenib

phenylalanine has been researched along with sorafenib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Imramovský, A; Kryštof, V; Páchniková, G; Slaninová, I; Uldrijan, S	1
Choi, HJ; Hong, HE; Hong, TH; Jeena, MT; Kim, KH; Kim, OH; Kim, SJ; Lee, KH; Ryu, JH	1

Other Studies

2 other study(ies) available for phenylalanine and sorafenib

Article	Year
Substituted 2-hydroxy-N-(arylalkyl)benzamide sensitizes cancer cells to metabolic stress by disrupting actin cytoskeleton and inhibiting autophagic flux. Toxicology in vitro : an international journal published in association with BIBRA, 2016, Volume: 37 Topics: Actin Cytoskeleton; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Niacinamide; Phenylalanine; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Stress, Physiological; Wound Healing	2016
Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells. Scientific reports, 2021, 01-13, Volume: 11, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Mitochondria; Organophosphorus Compounds; Peptides; Phenylalanine; Pyrenes; Reactive Oxygen Species; Sorafenib	2021

Article

Year

Substituted 2-hydroxy-N-(arylalkyl)benzamide sensitizes cancer cells to metabolic stress by disrupting actin cytoskeleton and inhibiting autophagic flux.

Toxicology in vitro : an international journal published in association with BIBRA, 2016, Volume: 37

Topics: Actin Cytoskeleton; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Niacinamide; Phenylalanine; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Stress, Physiological; Wound Healing

2016

Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells.

Scientific reports, 2021, 01-13, Volume: 11, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Mitochondria; Organophosphorus Compounds; Peptides; Phenylalanine; Pyrenes; Reactive Oxygen Species; Sorafenib

2021